Member Info for Soupdragon78

Exactly FX, what are Allenby doing to promote the company to large investors?

Doesn't look like it. Wait for certain posters who were previously championing the supposed Dr who knew all about NFX tech to now say it doesn't matter.

Higgins flogged off 5.75m

Indeed FX, the wonderful world of chartists, where they're always right because the chart only reflects the past.

'Its going down but one day it will turn and go up...'
'Look its going up just like I said it would...'

I get what you’re saying re. Anne, although I’m not that fussed about the state of the website as it’s immaterial to the nature of the company, more of an item to appease small PI’s.
The company isn’t marketing its product to the public so there’s no actual benefit to the company to have a website.

https://nuformix.com/pipeline/nxp002-fibrosis/

Looks like they updated the NXP002 page as well, a snazzy little graphic of someone with a padlock in their head.

Still says they are awaiting the second patent though.

Also like the way they've added the team photo's, so us shareholders can have Alastair glaring at us menacingly whilst we read his bio.

Ganners, maybe the company is trying to tell you when as they added a funky little red graph symbol to this page last night.

https://nuformix.com/about-nuformix/

Oxilio do want NXP001, the problem is they don't even have enough money to carry out their own work, let alone pay for the licence.

They had to sign up to the option as it was about to expire, if they had let it lapse then they wouldn't be able to say to potential funders that they had exclusivity. They had to do it to buy time.

Then they're a bunch of fannies.

Certainly feels like time to switch off until Oxilio pull their finger out and raise some money to finalise the license. Frustrating me now as I thought it would be sorted by April / mid May.

True chab, its Investopian selling out again. He posted his 550k and 712,777 buys on June 4 & 7th. Which coincidentally adds up to 1,262,777.

Someone flogged off another 1.2m

It shouldn't be too much of an issue, the recent FDA 503a bulks list was related to compounding drugs, so the ability for compounding pharmacies to use tranilast to create patient specific mixes.

Whilst tranilast itself doesn't have FDA approval, although it does have Orphan designation for maligant glioma, and also orphan status in the EU, which ever company licenses from NFX will be undergoing the usual 3 phase trials anyway. Just as they would if this was a brand new drug.

Certainly would make sense Mars.

"What is a Notice of Allowance?
A Notice of Allowance is a document sent to a patent applicant from the United States Patent and Trademark Office (USPTO) after a patent examiner has decided to issue the requested patent. The Notice of Allowance comes after the inventor has turned in a patent application and provided all information about the invention. This information includes the patent's description, design, drawings, or blueprints.

Since the Notice of Allowance shows the application is complete and meets all requirements, it is the final step in the long and complex patent application process. Your patent application has been fully reviewed and your invention has been given the green light for patenting. All that's left is to pay remaining fees and send any drawing corrections."

Wait for the 1 trade Chab, it’s all about the secret signals that we all know about!

FX, from what I can figure, the 'World' patent application is submitted, but there is no single global body who approve unilaterally. It is more of a single point for the process, the international body then undertake the search globally to test the 'patentability' of the application.

It is then up to the regional authorities to carry out their own examination and issuance of the patent.

Anyone selling now will be selling at a loss if they bought in the two and a bit months after the placing.

I’m 183cm and 80kg and wise enough not to waste my time grandstanding on an anonymous bulletin board.